Print

Rainer Rudolph Foundation Launches Search for Young Talents in Protein Biotechnology  
2/2/2012 10:49:46 AM

Halle, Germany, 2nd February 2012 – This year, the newly-established Rainer Rudolph Foundation will be awarding prizes to young researchers who have completed an outstanding final thesis (Bachelor's, Master's, Diploma or Doctoral as well as cooperations between academia and industry) in the fields of protein biochemistry and biotechnology. Each of the Foundation’s three prizes will be worth a total of €1,000 - applications should be submitted directly to the Foundation by 31st March 2012.

The Rainer Rudolph Foundation was established in 2011 by friends, companions, former colleagues and staff of the late Professor Dr. Rainer Rudolph on order to honour his outstanding scientific work. Prior to his passing in 2009, Professor Dr. Rudolph was among the world's leading protein biochemists as well as the co-founder of Scil Proteins GmbH, the company now sponsoring the Rainer Rudolph Foundation.

Dr. Ulrike Fiedler, CEO of the Foundation and CEO of Scil Proteins, said: "During his work, Professor Dr. Rudolph placed particular emphasis on linking scientific research with industrial applications and consequently, the foundation of Scil Proteins was a logical step for him. Through the years, we came to know and appreciate Professor Dr. Rudolph as a highly respected scientist and competent industrial partner. The Rainer Rudolph prizes have been established to encourage upcoming generations of scientists to excel in their work and therefore, I hope a lot of young researchers in the fields of protein biochemistry and biotechnology will apply."

The exact conditions for a Rainer Rudolph prize nomination can be found on the Foundation’s website: www.rainer-rudolph-stiftung.de.

About the Rainer Rudolph Foundation

The Rainer Rudolph Foundation was established in May 2011 as a charitable foundation to honour the work of Professor Dr. Rainer Rudolph as a scientifically-outstanding and internationally-leading protein biochemist. After his habilitation at the University of Regensburg in 1984, he worked for several years as a department manager at Boehringer Mannheim (now Roche Diagnostics). In 1994, he was offered a C4-professorship at the Martin-Luther-University Halle-Wittenberg and there, he managed to build a powerful technical biochemistry department. Together with Ulrike Fiedler and BioNet Holding GmbH, he founded Scil Proteins GmbH in 1999.

The Foundation will continue to address matters of particular concern to Rainer Rudolph such as the combination of academic and industrial research, the transformation of scientific insights into application and, in particular, the encouragement of young scientists. Its mission is to promote basic and applied research in the fields of protein biochemistry and biotechnology. The Foundation primarily addresses young scientists who have made extraordinary accomplishments in this area.

Administration:

Board

Dr. Ulrike Fiedler

Prof. Dr. Elisabeth Schwarz

Dr. Ulrich Opitz

Board of Trustees

Prof. Dr. Johannes Buchner

Prof. Dr. Gunter Fischer

Prof. Dr. Annette Beck-Sickinger

Dr. Dorothee Ambrosius

Prof. Dr. Franz-Xaver Schmid

About Scil Proteins

Scil Proteins is a biopharmaceutical company discovering and developing Affilin® molecules and working with industry partners in the development and manufacture of protein therapeutics and diagnostics. Affilin® therapeutics and diagnostics are highly stable proteins with a high affinity for target molecules and little immunogenity. Scil Proteins has built a pipeline of Affilin® therapeutics targeting cancer. In addition, the Company has a longstanding expertise in protein production and process development and, therefore, offers GMP contract biomanufacturing to its clients in the biotech and pharma industries. With state-of-the-art equipment and a particular expertise in refolding proteins, the Company has an excellent track record in supplying top level support for its partners. Scil Proteins has supported a number of different companies such as Roche, Actavis and Lundbeck in process development and manufacturing of recombinant protein drugs. Scil Proteins is a well-established private company located in Halle, Germany. To learn more about Scil Proteins, please visit www.scilproteins.com

Scil Proteins GmbH

Dr. Ulrike Fiedler

CEO

t: (Germany) +49 (0) 345 27 99 63 30

e: ulrike.fiedler@scilproteins.com

College Hill

Lauren McConville

Account Manager

t: (Germany) +49 (0) 89 52 05 92 12

e: scilproteins@collegehill.com


//-->